US 11,771,908 B2
Systems and methods for treatment of dry eye
Douglas Michael Ackermann, San Francisco, CA (US); Daniel Palanker, Palo Alto, CA (US); James Donald Loudin, Houston, TX (US); Garrett Cale Smith, San Francisco, CA (US); Victor Wayne McCray, San Jose, CA (US); and Brandon McNary Felkins, Half Moon Bay, CA (US)
Assigned to The Board of Trustees of the Leland Stanford Junior University, Stanford, CA (US)
Filed by The Board of Trustees of the Leland Stanford Junior University, Stanford, CA (US)
Filed on Jun. 24, 2020, as Appl. No. 16/911,221.
Application 16/911,221 is a continuation of application No. 16/195,719, filed on Nov. 19, 2018, granted, now 10,722,718.
Application 16/195,719 is a continuation of application No. 15/828,950, filed on Dec. 1, 2017, granted, now 10,143,846, issued on Dec. 4, 2018.
Application 15/828,950 is a continuation of application No. 14/816,846, filed on Aug. 3, 2015, abandoned.
Application 14/816,846 is a continuation of application No. 14/561,107, filed on Dec. 4, 2014, granted, now 9,095,723, issued on Aug. 4, 2015.
Application 14/561,107 is a continuation of application No. 13/298,042, filed on Nov. 16, 2011, granted, now 8,918,181, issued on Dec. 23, 2014.
Claims priority of provisional application 61/433,652, filed on Jan. 18, 2011.
Claims priority of provisional application 61/433,649, filed on Jan. 18, 2011.
Claims priority of provisional application 61/433,645, filed on Jan. 18, 2011.
Claims priority of provisional application 61/414,293, filed on Nov. 16, 2010.
Prior Publication US 2021/0008379 A1, Jan. 14, 2021
Int. Cl. A61N 1/37 (2006.01); A61N 1/372 (2006.01); A61N 1/36 (2006.01); A61N 1/375 (2006.01); A61N 1/378 (2006.01)
CPC A61N 1/37205 (2013.01) [A61N 1/3606 (2013.01); A61N 1/36046 (2013.01); A61N 1/36142 (2013.01); A61N 1/3756 (2013.01); A61N 1/3787 (2013.01); A61N 1/36057 (2013.01); A61N 1/37211 (2013.01)] 22 Claims
OG exemplary drawing
 
1. A method for treating dry eye in a patient, by stimulating comprising:
implanting a microstimulator adjacent to one or more nerves that innervate a lacrimal gland of the patient;
positioning a controller in proximity to the microstimulator when the patient is wearing a pair of eyeglasses with the controller embedded therein;
transferring a waveform generated by the controller to the microstimulator;
applying by the microstimulator a stimulation to the lacrimal gland from the waveform generated by the controller embedded in the pair of eyeglasses; and
recharging the controller embedded in the pair of eyeglasses worn by the patient after the applying stimulation step.